Nanostructured Lipid Carriers Delivering Sorafenib to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus Cancer Therapy

Jia-Yang Wang, Ya-Qi Song, Jing Peng, Hong-Lei Luo

DOI: 10.1021/acsomega.0c02072
Published: 2020-09-02
Container: ACS Omega
Publisher: American Chemical Society (ACS)
Open access: unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acsomega.0c02072,
  title = {Nanostructured Lipid Carriers Delivering Sorafenib
to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus
Cancer Therapy},
  author = {Jia-Yang Wang and Ya-Qi Song and Jing Peng and Hong-Lei Luo},
  year = {2020},
  journal = {ACS Omega},
  doi = {10.1021/acsomega.0c02072},
  url = {https://doi.org/10.1021/acsomega.0c02072}
}

RIS

TY  - JOUR
TI  - Nanostructured Lipid Carriers Delivering Sorafenib
to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus
Cancer Therapy
AU  - Jia-Yang Wang
AU  - Ya-Qi Song
AU  - Jing Peng
AU  - Hong-Lei Luo
PY  - 2020
JO  - ACS Omega
DO  - 10.1021/acsomega.0c02072
UR  - https://doi.org/10.1021/acsomega.0c02072
ER  -

APA

Wang, J., Song, Y., Peng, J., & Luo, H. (2020). Nanostructured Lipid Carriers Delivering Sorafenib to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus Cancer Therapy. ACS Omega. https://doi.org/10.1021/acsomega.0c02072

Source records

crossref · retrieved 2026-09-26T02:24:01.986Z